CAI-based systems and methods for the localized treatment of ocular and other diseases
US8614235B2 · kind B2 · utility
5Cited by
15References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2011 |
| Grant date | Dec 24, 2013 |
| Priority date | — |
| Expiry date | Jul 13, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention provides CAI compounds and formulations thereof, and methods for their use in the localized treatment of non-life threatening diseases. Formulations of CAI compounds of the subject invention include CAI free base and CAI prodrug microcrystallines, microparticles, emulsions, and the like. The subject invention further provides methods for treating non-life threatening diseases using the CAI compounds of the invention (i.e., novel delivery systems and combination therapies) that are effective and are associated with little or no adverse side effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.